Libyan study of 649 cases of Helicobacter‐negative gastritis: a distinct entity
DOI:
https://doi.org/10.54361/Keywords:
Helicobacter negative gastritis, Helicobacter positive gastritisAbstract
Background: The diagnosis of Helicobacter negative gastritis made when a pathologist recognizes the characteristic features of Helicobacter gastritis, but no bacteria can be detected by special stains. Aim: To know the local incidence and histomorphological pattern of Helicobacter negative gastritis, especially its association with intestinal metaplasia and dysplasia in gastric biopsies. Methods: Gastric biopsy cases were selected from database of Tripoli medical center from 2002 to 2008. The biopsies were assessed for the parameters as per revised Sydney System. The age, gender and the microscopic findings in the gastric biopsies were tabulated and analysed.Conclusion: Based on these results, Helicobacter negative gastritis is a common disease with the progression of atrophy, metaplasia and dysplasia that deserve further investigation.
Downloads
References
Kamangar F, Dawsey SM & Blaser MJ. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pyloriseropositivity. Journal of the National Cancer Institute 200; 698: 1445–1452.
Aktepe OC, Çiftçi IH, Şafak B, et al. Five methods for detection of Helicobacter pylori in the Turkish population. World of Gastroenterology 2011; 17(47):5172-5176.
Genta RM, Schuler CM & Lash RH. Helicobacter pylori-negative chronic active gastritis: a new entity or the result of widespread acid inhibition? 2008;134 ed.: A - 125.
Haber MM, Hunt B, Freston JW, et al. Changes of gastric histology in patients with erosive oesophagitis receiving long-term lansoprazole maintenance therapy. Aliment Pharmacol Ther. 2010; 32:83–96.
Peura DA, Haber MM, Hunt B, et al. Helicobacter pylori-negative gastritis in erosive esophagitis, nonerosive reflux disease or functional dyspepsia patients. J Clin Gastroenterol. 2010; 44:180–185.
Ozturk S, Serinsoz E, Kuzu I, et al. The Sydney System in the assessment of gastritis: Inter-observer agreement. The Turkish Journal of Gastroenterology 2001; 12:36-9.
Elbarghati L, Azzouz L, Laklouk I & Adiga BK. Histomorphology of Helicobacter positive gastric biopsies-Libyan study of 607 cases. LJMR 2016; 10 (2):1-13.
Nordenstedt H, David Y. Graham DY, Kramer JR, et al. Helicobacter pylori-Negative Gastritis: Prevalence and Risk factors. Am J Gastroenterol. 2013; 108(1):65–71.
Genta RM, Sonnenberg A. Helicobacter‐negative gastritis: a distinct entity unrelated to Helicobacter pylori infection. Alimentary pharmacology & therapeutics. 2015; 41 (2): 218-226.
Kiichi S, Ken K, Yushi T, et al. Distribution of Inflammation and Atrophy in the Stomach of Helicobacter pylori-Positive and -Negative Patients with Chronic Gastritis. American Journal of Gastroenterology. 1996; 91(5): 963-969.
Roland BC, Lee D, Salem A et al. Prevalence and Associated Risk Factors of Helicobacter pylori Negative Gastritis. J Gastrointest Dig Syst. 2016; 6:(1)1-7.
Graham DY, Genta R, Evans DG, et al. Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole. Am J Gastroenterol 1996;91:2120-2124.
Nakamura S, Matsumoto T, Ye H, et al. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma. A clinicopathologic and molecular study with reference to antibiotic treatment. Cancer. 2006;107(12):2770−2778.
Zaitoun AM. The prevalence of lymphoid follicles in Helicobacter pylori associated gastritis in patients with ulcers and non-ulcer dyspepsia. J Clin Pathol. 1995;48(4):325−329.
Broide E, Richter V, Mendlovic S, et al. Lymphoid follicles in children with Helicobacter pylori-negative gastritis Clinical & Experimental Gastroenterology. 2017;10:195-201.
Rosas-Blum E, Tatevian N, Hashmi SS, Rhoads JM, Navarro F. Non-specific gastric inflammation in children is associated with proton pump inhibitor treatment for more than 6 weeks. Front Pediatr. 2014;20:2−3.
Mazigh Mrad S, Abidi K, Brini I, Boukthir S, Sammoud A. Nodular gastritis: an endoscopic indicator of Helicobacter pylori infection in children. Tunis Med. 2012;90(11):789−792.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Elbarghati L, Azzouz L. (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
